Abstract
Schizophrenia is a severe and highly heritable disorder. Dystrobrevin-binding protein 1 (DTNBP1), also known as dysbindin-1, has been implicated in the pathophysiology of schizophrenia. Specifically, dysbindin-1 mRNA and protein expression are decreased in the brains of subjects with this disorder. Mice lacking dysbinidn-1 also display behavioral phenotypes similar to those observed in schizophrenic patients. However, it remains unknown whether deletion of dysbindin-1 impacts functions of the amygdala, a brain region that is critical for emotional processing, which is disrupted in patients with schizophrenia. Here, we show that dysbindin-1 is expressed in both excitatory and inhibitory neurons of the basolateral amygdala (BLA). Deletion of dysbindin-1 in male mice (Dys−/−) impaired cued and context-dependent threat memory, without changes in measures of anxiety. The behavioral deficits observed in Dys−/− mice were associated with perturbations in the BLA, including the enhancement of GABAergic inhibition of pyramidal neurons, increased numbers of parvalbumin interneurons, and morphological abnormalities of dendritic spines on pyramidal neurons. Our findings highlight an important role for dysbindin-1 in the regulation of amygdalar function and indicate that enhanced inhibition of BLA pyramidal neuron activity may contribute to the weakened threat memory expression observed in Dys−/− mice.
Highlights
Schizophrenia is a severe mental illness, characterized by positive, negative, and cognitive symptoms that affects 0.5–1% of population worldwide[1]
We used single molecule fluorescent in situ hybridization to determine the cellular localization of dysbindin-1 mRNA within the amygdala
Our findings demonstrate that the genetic ablation of dysbindin-1, a protein expressed in both excitatory neurons and inhibitory interneurons of the basolateral amygdala (BLA), impaired the fear response of conditioned threat memory in mice, which was associated with cellular, structural, and functional abnormalities in the amygdala
Summary
Schizophrenia is a severe mental illness, characterized by positive (delusions), negative (anhedonia), and cognitive symptoms that affects 0.5–1% of population worldwide[1]. A recent study demonstrated that human schizophrenia subjects with genetic variants in the gene that encodes dysbindin-1 (DTNBP1) exhibited cognitive dysfunction[6]. Dysbindin-1 knockout mice (Dys−/−) exhibit behavioral phenotypes similar to what is observed in schizophrenia, including reduced pre-pulse inhibition, impaired learning and memory, and decreased social interaction[7,8,9,10,11,12,13]. These data suggest that alterations in dysbindin-1 expression can contribute to the pathophysiology of schizophrenia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.